Add BrightSurf on Google Email

Massachusetts Institute of Technology Department of Biology


New AI model could cut the costs of developing protein drugs

MIT researchers used a large language model to optimize the genetic sequences of proteins manufactured by yeast, reducing production costs. The new model predicted which codons would work best for manufacturing six different proteins, including human growth hormone and a monoclonal antibody, with successful results.

SourceMassachusetts Institute of Technology Department of Biology·JournalProceedings of the National Academy of Sciences·DateFeb 17, 2026

Differences in T cells’ functional state determine resistance to cancer therapy

Researchers found that certain T cells stop working before entering the tumor due to changes in gene expression, making ICB therapies less effective. Combining ICB with other forms of immunotherapy targeting different aspects of T cell function may improve response rates for non-small cell lung cancer patients.

SourceMassachusetts Institute of Technology Department of Biology·JournalScience Immunology·TypeExperimental study·DateOct 29, 2021